Cannabis pharmaceutical company MediPharm Labs is positioned to capitalize from Germany’s upcoming legalization of the psychoactive plant. Germany’s upper house, the Bundesrat, passed legislation to partially legalize cannabis starting April 1, allowing adults to cultivate, possess and store the plant for personal consumption.
(Source: promesaartstudio.)
Click here for the full story.
Weekly Update – Top Cannabis News Stories
1 | Top Story: One of Canada’s first cannabis stocks looks to raise capital as cannabis stocks surge
2 | Biopharmaceutical company launches 10 per cent CBD (THC free) formula in Canada
3 | Introducing the newest ready-to-drink canned cocktails
Top Cannabis Stocks March 22 to March 28, 2024
1. T.WEED | 34,373 views | Canopy Growth Corp.
2. T.TLRY | 26,384 views | Tilray Brands Inc.
3.T.LABS | 17,923 views | Medipharm Labs Corp.
4. T.CURA | 4,579 views | Curaleaf Holdings Inc.
5. T.OGI | 2,445 views | OrganiGram Inc.
6.T.ACB| 2,324 views | Aurora Cannabis Inc.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.